Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The Eversense® E3 Smart Transmitter can be paired to only one mobile device at a time.
At this time, the Eversense® E3 Smart Transmitter is only available in dark gray.
However users can go to pumppeelz.com and order from a variety of designer decals that can be shipped globally.
| Characteristics | Description |
|---|---|
| Class | II |
| Type | AC Input, 100-240Vac, 50/60Hx, 0.3-0.15A |
| DC Output | 5V DC, 1A (5.0 watts) |
| Moisture Protection (charging cradle) | IP22 (Protected from touch by fingers and objects greater than 12 millimeters. Protected from water spray or dripping water from vertical angle.) |
To unpair an old transmitter, go to the Main Menu in the App and tap Connect. Tap and hold the
name of your old smart transmitter. Tap OK to stop the app from automatically connecting with the old smart transmitter. Follow the steps in the user guide for linking the new transmitter to your sensor.
The system will send out a notification on day 330, and alerts on days 366, 395, and 396 reminding the user to order a new smart transmitter. After day 395, the smart transmitter will no longer be able to provide CGM data to you.
On day 22 and beyond, after a successful calibration, you’ll be notified if the calibration frequency changes.
Additionally, the Calibrate screen (Menu → Calibrate) will always indicate the current phase that the system is in.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060